News
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2018
ESSA Appoints Otello Stampacchia, Ph.D., of Omega Funds to Board of Directors
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2018
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2018
BRANDED_51083730-v6-ESSA – News Release re Nasdaq Compliance
ESSA TO PRESENT AT BLOOM BURTON & CO. HEALTHCARE INVESTOR CONFERENCE 2018
ESSA Pharma Inc. Announces Completion of Share Consolidation
ESSA Pharma Enhances R&D Capabilities with Two New Key Hires
ESSA Pharma Inc. Announces Share Consolidation
ESSA Pharma Inc. Reports Results of Annual General And Special Meeting of Shareholders